Johnson MS - Search Results

1

A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma.

Yu S, Yu M, Keane B, Mauro DM, Helft PR, Harris WP, Sanoff HK, Johnson MS, O'Neil B, McRee AJ, Somasundaram A. Yu S, et al. Among authors: johnson ms. Oncologist. 2024 Mar 4;29(3):270-e413. doi: 10.1093/oncolo/oyad331. Oncologist. 2024. PMID: 38325328 Free PMC article. Clinical Trial.

2

Radioembolization With Chemotherapy for Colorectal Liver Metastases: A Randomized, Open-Label, International, Multicenter, Phase III Trial.

Mulcahy MF, Mahvash A, Pracht M, Montazeri AH, Bandula S, Martin RCG 2nd, Herrmann K, Brown E, Zuckerman D, Wilson G, Kim TY, Weaver A, Ross P, Harris WP, Graham J, Mills J, Yubero Esteban A, Johnson MS, Sofocleous CT, Padia SA, Lewandowski RJ, Garin E, Sinclair P, Salem R; EPOCH Investigators. Mulcahy MF, et al. Among authors: johnson ms. J Clin Oncol. 2021 Dec 10;39(35):3897-3907. doi: 10.1200/JCO.21.01839. Epub 2021 Sep 20. J Clin Oncol. 2021. PMID: 34541864 Free PMC article. Clinical Trial.

3

The evolving role of radioembolization in hepatocellular carcinoma.

Johnson MS. Johnson MS. Clin Adv Hematol Oncol. 2017 Aug;15 Suppl 9(8):14-17. Clin Adv Hematol Oncol. 2017. PMID: 29036038 No abstract available.

4

Microsphere localization and dose quantification using positron emission tomography/CT following hepatic intraarterial radioembolization with yttrium-90 in patients with advanced hepatocellular carcinoma.

Lea WB, Tapp KN, Tann M, Hutchins GD, Fletcher JW, Johnson MS. Lea WB, et al. Among authors: johnson ms. J Vasc Interv Radiol. 2014 Oct;25(10):1595-603. doi: 10.1016/j.jvir.2014.06.028. Epub 2014 Aug 23. J Vasc Interv Radiol. 2014. PMID: 25156647

5

Comparison of hepatic MDCT, MRI, and DSA to explant pathology for the detection and treatment planning of hepatocellular carcinoma.

Ladd LM, Tirkes T, Tann M, Agarwal DM, Johnson MS, Tahir B, Sandrasegaran K. Ladd LM, et al. Among authors: johnson ms. Clin Mol Hepatol. 2016 Dec;22(4):450-457. doi: 10.3350/cmh.2016.0036. Epub 2016 Dec 14. Clin Mol Hepatol. 2016. PMID: 27987537 Free PMC article.

6

The diagnosis and treatment of hepatocellular carcinoma.

Hartke J, Johnson M, Ghabril M. Hartke J, et al. Semin Diagn Pathol. 2017 Mar;34(2):153-159. doi: 10.1053/j.semdp.2016.12.011. Epub 2016 Dec 20. Semin Diagn Pathol. 2017. PMID: 28108047 Review.

7

The treatment path in hepatocellular carcinoma.

El-Serag HB, Zhu AX, Johnson MS. El-Serag HB, et al. Among authors: johnson ms. Clin Adv Hematol Oncol. 2017 Aug;15 Suppl 9(8):1-20. Clin Adv Hematol Oncol. 2017. PMID: 29036035

8

The treatment path in hepatocellular carcinoma: Further observations.

Johnson MS. Johnson MS. Clin Adv Hematol Oncol. 2017 Aug;15 Suppl 9(8):18. Clin Adv Hematol Oncol. 2017. PMID: 29036039 No abstract available.

9

Response and Overall Survival for Yttrium-90 Radioembolization of Hepatic Sarcoma: A Multicenter Retrospective Study.

Miller MD, Sze DY, Padia SA, Lewandowski RJ, Salem R, Mpofu P, Haste PM, Johnson MS. Miller MD, et al. Among authors: johnson ms. J Vasc Interv Radiol. 2018 Jun;29(6):867-873. doi: 10.1016/j.jvir.2018.01.775. Epub 2018 Apr 30. J Vasc Interv Radiol. 2018. PMID: 29724518 Free article.

10

Multidisciplinary Management of Patients with Unresectable Hepatocellular Carcinoma: A Critical Appraisal of Current Evidence.

Gholam PM, Iyer R, Johnson MS. Gholam PM, et al. Among authors: johnson ms. Cancers (Basel). 2019 Jun 22;11(6):873. doi: 10.3390/cancers11060873. Cancers (Basel). 2019. PMID: 31234476 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

914 results

Search Page

Filters